Turning Open-Label Extensions into Engines of Real World Evidence

Explore four key principles for transforming open-label extension studies (OLEs) into a strategic connector of real world evidence across the development lifecycle.

For years, open-label extension studies (OLEs) have played a quiet, almost administrative role in clinical development. They offer study participants continued access to investigational treatments after the pivotal trial ends and are often pursued in the fields of chronic disease, oncology, rare disease and neuroscience.

Yet, in today’s data-rich, patient-centered research environment, OLEs can serve a larger purpose.  When thoughtfully designed, an OLE can become a hybrid platform that preserves the rigor of clinical follow-up while embracing the scale and texture of real world data.

In this article, you’ll explore ways to:

• Design open-label extension studies with clear strategic objectives that support real-world evidence generation.
• Ways to integrate real world data and patient-centered insights while maintaining scientific rigor.
• Practical principles for aligning regulatory, data and operational teams to maximize the value of OLEs.

Download the article to learn how thoughtful OLE design can extend the value of clinical trials and generate meaningful real world evidence to support long-term development, regulatory and access strategies.